Gabapentin

Product NDC
53002-3423
11-digit product format
530023423
Labeler code
53002
Product ID
53002-3423_c106dd29-d11a-4299-ad56-695b61129c7a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Gabapentin
Dosage form
CAPSULE
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA075350
Marketing category
ANDA
Marketing start
2014-04-03
Marketing end
0000-00-00
Substance
GABAPENTIN
Active strength
300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
6CW7F3G59XGABAPENTIN60142-96-3GABAPENTIN

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
53002-3423-053002342300100 CAPSULE in 1 BOTTLE (53002-3423-0) 100 capsule2020-01-010000-00-00NoNoCurrent
53002-3423-35300234230330 CAPSULE in 1 BOTTLE (53002-3423-3) 30 capsule2020-01-010000-00-00NoNoCurrent
53002-3423-65300234230660 CAPSULE in 1 BOTTLE (53002-3423-6) 60 capsule2020-01-010000-00-00NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
GabapentinRPK Pharmaceuticals, Inc.2023-06-07HUMAN PRESCRIPTION DRUG LABEL3